Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts

Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
  • Major roles of the circadian clock in cancer
  • Metabolic regulation of immune responses to cancer
  • Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
  • Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
  • Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Articles

  • You have access
    Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
    Mei Feng, Fangyanni Wang, Xinyu Liu, Tingting Hao, Ning Zhang, Mi Deng, Yisheng Pan and Ruirui Kong
    Cancer Biology & Medicine May 2023, 20230019; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0019
  • You have access
    Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
    Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
    Cancer Biology & Medicine May 2023, 20220761; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
  • You have access
    Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
    Hongxia Chen, Luxi Yin, Jie Yang, Ningxin Ren, Jinna Chen, Qixuan Lu, Ying Huang, Yanru Feng, Weihu Wang, Shulian Wang, Yueping Liu, Yongwen Song, Yexiong Li, Jing Jin, Wen Tan and Dongxin Lin
    Cancer Biology & Medicine April 2023, 20 (4) 297-316; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0711
  • You have access
    Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
    Wenzhe Yi, Dan Yan, Dangge Wang and Yaping Li
    Cancer Biology & Medicine April 2023, 20 (4) 248-267; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0009
  • You have access
    Erratum to Intercellular transmission of cGAS-STING signaling in cancer
    Qirou Wu, Xiaohong Leng and Pinglong Xu
    Cancer Biology & Medicine April 2023, 20 (4) 317-318; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0087
  • You have access
    Facing challenges with hope: universal immune cells for hematologic malignancies
    Yuqing Wang, Ruihao Huang, Zheng Wang, Jingkang Xiong, Xiaoqi Wang and Xi Zhang
    Cancer Biology & Medicine April 2023, 20 (4) 229-247; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0759
View more latest articles

Cover Story

Current issue

Cancer Biology & Medicine: 20 (4)
Cancer Biology & Medicine
Vol. 20, Issue 4
15 Apr 2023
  • Table of Contents
  • Index by author

Submit

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Back to top

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire